The Comparison of Genes and Molecular Pathway between Newly Diagnosed and Relapsed Acute Lymphocytic Leukemia (ALL) Patients: A Bioinformatics Analysis
نویسندگان
1 Asadabad school of medical sciences, Asadabad, Iran - Asadabad school of medical sciences, Asadabad, Iran
2 Emergency Medicine Department, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran - Emergency Medicine Department, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
3 School of medicines, Jundishapur University of Medical Sciences, Ahvaz, Iran - School of medicines, Jundishapur University of Medical Sciences, Ahvaz, Iran
4 Alborz University of Medical Sciences, Alborz, Iran - Alborz University of Medical Sciences, Alborz, Iran
5 Assistant Professor of Pediatric Hematology and Oncology Department of Pediatrics, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran - Assistant Professor of Pediatric Hematology and Oncology Department of Pediatrics, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
doi
10.18502/ijpho.v16i1.20424چکیده
Background: Acute lymphoblastic leukemia (ALL) is among the most common cancers in children, which leads to the death of many patients. ALL patients include new cases and the relapsed ones. The common genes between these two conditions can largely help in managing patients and preventing future relapses. Therefore, this study ...
